The movement disorders team is actively involved in clinical research studies to find new and innovative ways to treat movement disorders. Our physicians are examining the role of genetics in the cause of Parkinson’s disease. The program is an active investigative site for the Parkinson Study Group, a consortium of the most prestigious academic programs in North America designed to evaluate new treatments for Parkinson’s disease, independent of the influence of the pharmaceutical industry.

The center's physcians are also members of the Huntington’s Study Group and studies sponsored by the group are underway to find new and innovative ways to treat Huntington’s disease. A number of research studies to determine the causes and new treatment options for restless leg syndrome (RLS) are also underway.

Damien Shin, PhD

Our research scientist, Damien Shin, PhD, studies basic and translational research in movement disorders as well as mechanisms of deep brain stimulation (DBS).